Skip to content
healthcare.dev

CHOLESTYRAMINE

NDC 70771-1070, CHOLESTYRAMINE, powder, for suspension, from Zydus Lifesciences Limited.

Product NDC
70771-1070
Status
Listed
Labeler
Zydus Lifesciences Limited
Dosage form
POWDER, FOR SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA202902
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70771-1070 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CHOLESTYRAMINE4 g/5.5g

Pharmacologic classes

Bile Acid Sequestrant [EPC]; Bile-acid Binding Activity [MoA]

Package NDCNDC-11Package
70771-1070-170771107001231 g in 1 CONTAINER (70771-1070-1)
70771-1070-27077110700260 POUCH in 1 CARTON (70771-1070-2) / 5.5 g in 1 POUCH

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/d7c6bc5e-1916-43bf-b943-98f00f41b8de

Use it

Look up 70771-1070 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70771-1070 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70771-1070. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.